Trump Targets Faster Access to Psychedelic Drugs for Mental Health. Here What That Means ...

President Trump issued an executive order to fast-track psychedelic therapies like ibogaine to treat PTSD and other mental ...

WASHINGTON (AP) — Surging interest in the purported benefits of psychedelic drugs has given rise to books, documentaries and ...

The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for ...

Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.

The order eases restrictions on psychedelic drugs like ibogaine to spur research on using them for medical purposes.

The agency issued priority vouchers for 3 experimental new drugs using psilocybin and methylone, amid Trump’s ...

The move comes less than a week later after President Donald Trump signed an executive order to extend research to study ...

FDA commissioner Marty Makary told NBC News that the first psychedelic drug could be approved in the U.S. as soon as this ...

Different psychedelics create very similar brain pattern activity, giving scientists new insight into potential mental health treatments.

Studies show that ibogaine can be effective for short-term opioid addiction treatment, especially reducing drug cravings and some withdrawal symptoms.

The order calls for the FDA to give expedited consideration to certain psychedelic drugs.